- Foundayo, a daily GLP-1 weight loss pill produced by Eli Lilly, has been approved in the UK for treating both weight loss and type 2 diabetes.
- The UK is the first country in Europe to approve the drug for both conditions, although it will only be available via private prescription and not on the NHS.
- Unlike rival oral treatment Wegovy, Foundayo can be taken once daily without any food or water restrictions.
- The drug is set to launch in the UK later this month at a lower list price than Mounjaro, which currently costs £330 for a monthly supply.
- While offering clinically meaningful weight loss, potential side effects of the medication include nausea, diarrhoea, stomach cramps, fatigue, and hair loss.
IN FULL
